|
Harbin Jixianglong Biotech Co., Ltd.
|
Lanreotide CAS No. 108736-35-2
Sequence: H-D-2-NAL-CYS-TYR-D-TRP-LYS-VAL-CYS-THR-NH2
Lanreotide is used to treat acromegaly and syndromes caused by neuroendocrine tumors. It is similar to octreotide which is a long-acting somatostatin analog.
| Product Name |
Lanreotide (Acetate) |
| CAS NO. |
108736-35-2 |
| Appearance |
White Powder/ Freeze-Dried Powder |
| Purity |
>98% or customized |
| Application |
Drug peptides |
| Usage |
Lanreotide is used to treat acromegaly and syndromes caused by neuroendocrine tumors. |
Related Products
| Name |
CAS No. |
Name |
CAS No. |
| Eptifibatide |
188627-80-7 |
Thymalfasin |
69440-99-9 |
| Terlipressin Acetate |
14636-12-5 |
Thymopentin Acetate (TP-5) |
69558-55-0 |
| Astosiban Acetate |
90779-69-4 |
Octreotide Acetate |
83150-76-9 |
| Liraglutide |
204656-20-2 |
Melanotan II Acetate |
121062-08-6 |
| Teriparatide |
52232-67-4 |
Melanotan I Acetate |
75921-69-6 |
| Bivalirudin |
128270-60-0 |
Secretin Acetate |
17034-35-4 |
| Carbetocin |
37025-55-1 |
Ornipressin Acetate |
3397-23-7 |
| Thymosin Beta 4 |
77591-33-4 |
Oxytocin Acetate |
50-56-6 |
| Calcitonin |
60731-46-6 |
Lypressin Acetate |
50-57-7 |
| Semaglutide |
910463-68-2 |
Argpressin Acetate |
113-79-1 |
| Abaloparatide |
247062-33-5 |
Calcitonin (Salmone) Acetate |
47931-85-1 |
  Company Profile
Founded in 2011, Harbin Jixianglong Biotech Co., Ltd. is a is a professional high-tech company specializing in R&D and production of polypeptide pharmaceuticals. Our advanced industry chain occupied in R&D, approbation and industrialization of peptides API and preparation.
Jixianglong has peptide drug production workshop and pilot workshop for personalized cancer neoantigen peptide vaccine which approved by GMP standard. More than 300 sets advanced instruments for production and testing, such as Solid phase synthesizer, Preparative liquid chromatograph, Freeze dryer, High performance liquid chromatograph etc.
Main Products:
10 items completed polypeptide API declared:
Eptifibatide, Somatostatin, Terlipressin Acetate, Thymalfasin, Atosiban Acetate, Carbetocin, Oxytocin, Ganirelix Acetate, Octreotide Acetate, Cetrorelix Acetate.
N items as researching reserve series:
Teriparatide, Bivalirudin, Liraglutide, Nesiritide, Abaloparatide, Semaglutide, Personalized cancer neoantigen peptide vaccine, Peptide drug conjugate (PDC).
 
|
Send Inquiry
|
Pharma Sources Insight June 2024: Globalization on the Go
